Sivera, R.; Sevilla, T.; Vílchez, JJ.; Martínez-Rubio, D.; Chumillas, MJ.; Vázquez, JF.; Muelas, N.... (2013). Charcot-Marie-Tooth disease: Genetic and clinical spectrum in a Spanish clinical series. Neurology. 81(18):1617-1625. https://doi.org/10.1212/WNL.0b013e3182a9f56a
Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/201249
Título:
|
Charcot-Marie-Tooth disease: Genetic and clinical spectrum in a Spanish clinical series
|
Autor:
|
Sivera, Rafael
Sevilla, T.
Vílchez, Juan Jesús
Martínez-Rubio, Dolores
Chumillas, María José
Vázquez, Juan Francisco
Muelas, Nuria
Bataller, Luis
Millán, José María
Palau, Francesc
Espinós-Armero, Carmen Ángeles
|
Entidad UPV:
|
Universitat Politècnica de València. Escuela Técnica Superior de Ingeniería Agronómica y del Medio Natural - Escola Tècnica Superior d'Enginyeria Agronòmica i del Medi Natural
|
Fecha difusión:
|
|
Resumen:
|
[EN] Objectives: To determine the genetic distribution and the phenotypic correlation of an extensive series of patients with Charcot-Marie-Tooth disease in a geographically well-defined Mediterranean area.
Methods: A ...[+]
[EN] Objectives: To determine the genetic distribution and the phenotypic correlation of an extensive series of patients with Charcot-Marie-Tooth disease in a geographically well-defined Mediterranean area.
Methods: A thorough genetic screening, including most of the known genes involved in this disease, was performed and analyzed in this longitudinal descriptive study. Clinical data were analyzed and compared among the genetic subgroups.
Results: Molecular diagnosis was accomplished in 365 of 438 patients (83.3%), with a higher success rate in demyelinating forms of the disease. The CMT1A duplication (PMP22 gene) was the most frequent genetic diagnosis (50.4%), followed by mutations in the GJB1 gene (15.3%), and in the GDAP1 gene (11.5%). Mutations in 13 other genes were identified, but were much less frequent. Sixteen novel mutations were detected and characterized phenotypically.
Conclusions: The relatively high frequency of GDAP1 mutations, coupled with the scarceness of MFN2 mutations (1.1%) and the high proportion of recessive inheritance (11.6%) in this series exemplify the particularity of the genetic distribution of Charcot-Marie-Tooth disease in this region.
[-]
|
Palabras clave:
|
Charcot-Marie-Tooth disease
,
Genetic distribution
,
GDAP1
|
Derechos de uso:
|
Reserva de todos los derechos
|
Fuente:
|
Neurology. (eissn:
0028-3878
)
|
DOI:
|
10.1212/WNL.0b013e3182a9f56a
|
Editorial:
|
Ovid Technologies (Wolters Kluwer) - American Academy of Neurology
|
Versión del editor:
|
https://doi.org/10.1212/WNL.0b013e3182a9f56a
|
Código del Proyecto:
|
info:eu-repo/grantAgreement/MICINN//CP08%2F00053/ES/CP08%2F00053/
...[+]
info:eu-repo/grantAgreement/MICINN//CP08%2F00053/ES/CP08%2F00053/
info:eu-repo/grantAgreement/MICINN//PI08%2F90857/ES/RACIONALIZACIÓN DEL DIAGNÓSTICO MOLECULAR DE LAS ENFERMEDADES GENÉTICAS RARAS: EL MODELO DE LA NEUROPATÍA DE CHARCOT-MARIE-TOOTH/
info:eu-repo/grantAgreement/MINECO//PI12%2F00453/ES/Investigación traslacional y mecanismos de enfermedad en neuropatías periféricas hereditarias/
info:eu-repo/grantAgreement/ISCIII//IR11%2FTREAT-CMT//Translational Research, Experimental Medicine and Therapeutics on Charcot-Marie-Tooth disease /
info:eu-repo/grantAgreement/ISCIII//PI08%2F90857/
info:eu-repo/grantAgreement/ISCIII//PI08%2F0889/
info:eu-repo/grantAgreement/ISCIII//CP08%2F00053/
info:eu-repo/grantAgreement/ISCIII//PI12%2F00453//Investigación traslacional y mecanismos de enfermedad en neuropatías periféricas hereditarias/
info:eu-repo/grantAgreement/ISCIII//PI12%2F0946/
info:eu-repo/grantAgreement/Conselleria d'Educació, Investigació, Cultura i Esport de la Generalitat Valenciana//Prometeo%2F2009%2F05/
[-]
|
Agradecimientos:
|
This collaborative joint project is awarded by IRDiRC and funded by the Instituto de Salud Carlos III (ISCIII)-Subdireccion General de Evaluacion y Fomento de la Investigacion within the framework of the National R+D+I ...[+]
This collaborative joint project is awarded by IRDiRC and funded by the Instituto de Salud Carlos III (ISCIII)-Subdireccion General de Evaluacion y Fomento de la Investigacion within the framework of the National R+D+I Plan (grants IR11/TREAT-CMT, PI08/90857, PI08/0889, CP08/00053, PI12/00453, and PI12/0946), cofunded with FEDER funds, and the Generalitat Valenciana (grant Prometeo/2009/051). The Centro de Investigacion Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED) and the Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER) are initiatives from the ISCIII.
[-]
|
Tipo:
|
Artículo
|